Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,092)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| CG Oncology, Inc. | CGON | $62.24 | $5.53B | — | |
| Waystar Holding Corp. | WAY | $28.84 | $5.53B | 41.2 | — |
| Teleflex Incorporated | TFX | $130.40 | $5.53B | 1.04% | |
| Kodiak Sciences Inc. | KOD | $87.72 | $5.51B | — | |
| Merit Medical Systems, Inc. | MMSI | $91.40 | $5.46B | 37.6 | — |
| Cogent Biosciences, Inc. | COGT | $31.43 | $5.45B | — | |
| Mirum Pharmaceuticals, Inc. | MIRM | $83.44 | $5.42B | — | |
| RadNet, Inc. | RDNT | $68.41 | $5.38B | — | |
| Regencell Bioscience Holdings Limited | RGC | $10.80 | $5.36B | — | |
| Haemonetics Corporation | HAE | $117.11 | $5.33B | 56.6 | — |
| Oruka Therapeutics, Inc. | ORKA | $79.92 | $5.29B | — | |
| Scholar Rock Holding Corporation | SRRK | $43.00 | $5.24B | — | |
| PTC Therapeutics, Inc. | PTCT | $62.62 | $5.23B | — | |
| Stevanato Group S.p.A. | STVN | $18.82 | $5.14B | 33.0 | 0.32% |
| Grifols, S.A. | GRFS | $7.50 | $5.10B | 9.7 | 1.41% |
| Sotera Health Company | SHC | $17.77 | $5.07B | 31.2 | — |
| Erasca, Inc. | ERAS | $14.49 | $5.07B | — | |
| MiniMed Group, Inc. | MMED | $17.80 | $5.01B | — | |
| Concentra Group Holdings Parent, Inc. | CON | $39.09 | $4.98B | 25.2 | 0.65% |
| Travere Therapeutics, Inc. | TVTX | $52.58 | $4.96B | — | |
| CRISPR Therapeutics AG | CRSP | $50.50 | $4.88B | — | |
| Heartflow, Inc. | HTFL | $55.82 | $4.85B | — | |
| Definium Therapeutics, Inc. | DFTX | $35.49 | $4.77B | — | |
| LifeStance Health Group, Inc. | LFST | $12.33 | $4.69B | 94.9 | — |
| Option Care Health, Inc. | OPCH | $31.29 | $4.69B | 23.7 | — |
| BillionToOne, Inc. | BLLN | $104.67 | $4.62B | 148.3 | — |
| Tango Therapeutics, Inc. | TNGX | $26.98 | $4.55B | — | |
| Dianthus Therapeutics, Inc. | DNTH | $78.10 | $4.37B | — | |
| LivaNova PLC | LIVN | $78.44 | $4.31B | 23.2 | — |
| Integer Holdings Corporation | ITGR | $126.70 | $4.31B | 34.6 | — |
| Edgewise Therapeutics, Inc. | EWTX | $39.65 | $4.31B | — | |
| Indivior Pharmaceuticals, Inc. | INDV | $34.79 | $4.11B | 12.5 | — |
| Adaptive Biotechnologies Corporation | ADPT | $25.33 | $4.04B | — | |
| Relay Therapeutics, Inc. | RLAY | $18.41 | $4.03B | — | |
| ICU Medical, Inc. | ICUI | $160.84 | $4.02B | 135.2 | — |
| Arcutis Biotherapeutics, Inc. | ARQT | $31.87 | $4.01B | 138.6 | — |
| AbCellera Biologics Inc. | ABCL | $12.24 | $3.97B | — | |
| iRhythm Holdings, Inc. | IRTC | $113.55 | $3.74B | — | |
| Envista Holdings Corporation | NVST | $23.19 | $3.72B | 39.3 | — |
| Veracyte, Inc. | VCYT | $46.22 | $3.72B | 33.0 | — |
| National HealthCare Corporation | NHC | $235.60 | $3.69B | 26.5 | 1.08% |
| Pulse Biosciences, Inc. | PLSE | $51.31 | $3.66B | — | |
| Amylyx Pharmaceuticals, Inc. | AMLX | $29.03 | $3.64B | — | |
| Legend Biotech Corporation | LEGN | $18.63 | $3.62B | — | |
| Organon & Co. | OGN | $13.75 | $3.61B | 17.6 | 0.58% |
| Xenon Pharmaceuticals Inc. | XENE | $35.95 | $3.48B | — | |
| Acadia Pharmaceuticals Inc. | ACAD | $20.19 | $3.48B | 9.1 | — |
| Liquidia Corporation | LQDA | $38.86 | $3.48B | 28.0 | — |
| Parabilis Medicines, Inc. | PBLS | $27.85 | $3.44B | — | |
| IDEAYA Biosciences, Inc. | IDYA | $35.47 | $3.42B | — |
CG Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $5.53B
- P/E
- unprofitable
Waystar Holding Corp.
Healthcare / Health Information Services
- Market Cap
- $5.53B
- P/E
- 41.2
Teleflex Incorporated
Healthcare / Medical Instruments & Supplies
- Market Cap
- $5.53B
- P/E
- unprofitable
- Dividend Yield
- 1.04%
Kodiak Sciences Inc.
Healthcare / Biotechnology
- Market Cap
- $5.51B
- P/E
- unprofitable
Merit Medical Systems, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $5.46B
- P/E
- 37.6
Cogent Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $5.45B
- P/E
- unprofitable
Mirum Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $5.42B
- P/E
- unprofitable
RadNet, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $5.38B
- P/E
- unprofitable
Regencell Bioscience Holdings Limited
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $5.36B
- P/E
- unprofitable
Haemonetics Corporation
Healthcare / Medical Devices
- Market Cap
- $5.33B
- P/E
- 56.6
Oruka Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $5.29B
- P/E
- unprofitable
Scholar Rock Holding Corporation
Healthcare / Biotechnology
- Market Cap
- $5.24B
- P/E
- unprofitable
PTC Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $5.23B
- P/E
- unprofitable
Stevanato Group S.p.A.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $5.14B
- P/E
- 33.0
- Dividend Yield
- 0.32%
Grifols, S.A.
Healthcare / Drug Manufacturers - General
- Market Cap
- $5.10B
- P/E
- 9.7
- Dividend Yield
- 1.41%
Sotera Health Company
Healthcare / Diagnostics & Research
- Market Cap
- $5.07B
- P/E
- 31.2
Erasca, Inc.
Healthcare / Biotechnology
- Market Cap
- $5.07B
- P/E
- unprofitable
MiniMed Group, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $5.01B
- P/E
- unprofitable
Concentra Group Holdings Parent, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $4.98B
- P/E
- 25.2
- Dividend Yield
- 0.65%
Travere Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $4.96B
- P/E
- unprofitable
CRISPR Therapeutics AG
Healthcare / Biotechnology
- Market Cap
- $4.88B
- P/E
- unprofitable
Heartflow, Inc.
Healthcare / Health Information Services
- Market Cap
- $4.85B
- P/E
- unprofitable
Definium Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $4.77B
- P/E
- unprofitable
LifeStance Health Group, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $4.69B
- P/E
- 94.9
Option Care Health, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $4.69B
- P/E
- 23.7
BillionToOne, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $4.62B
- P/E
- 148.3
Tango Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $4.55B
- P/E
- unprofitable
Dianthus Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $4.37B
- P/E
- unprofitable
LivaNova PLC
Healthcare / Medical Devices
- Market Cap
- $4.31B
- P/E
- 23.2
Integer Holdings Corporation
Healthcare / Medical Devices
- Market Cap
- $4.31B
- P/E
- 34.6
Edgewise Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $4.31B
- P/E
- unprofitable
Indivior Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $4.11B
- P/E
- 12.5
Adaptive Biotechnologies Corporation
Healthcare / Diagnostics & Research
- Market Cap
- $4.04B
- P/E
- unprofitable
Relay Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $4.03B
- P/E
- unprofitable
ICU Medical, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $4.02B
- P/E
- 135.2
Arcutis Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $4.01B
- P/E
- 138.6
AbCellera Biologics Inc.
Healthcare / Biotechnology
- Market Cap
- $3.97B
- P/E
- unprofitable
iRhythm Holdings, Inc.
Healthcare / Medical Devices
- Market Cap
- $3.74B
- P/E
- unprofitable
Envista Holdings Corporation
Healthcare / Medical Instruments & Supplies
- Market Cap
- $3.72B
- P/E
- 39.3
Veracyte, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $3.72B
- P/E
- 33.0
National HealthCare Corporation
Healthcare / Medical Care Facilities
- Market Cap
- $3.69B
- P/E
- 26.5
- Dividend Yield
- 1.08%
Pulse Biosciences, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $3.66B
- P/E
- unprofitable
Amylyx Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $3.64B
- P/E
- unprofitable
Legend Biotech Corporation
Healthcare / Biotechnology
- Market Cap
- $3.62B
- P/E
- unprofitable
Organon & Co.
Healthcare / Drug Manufacturers - General
- Market Cap
- $3.61B
- P/E
- 17.6
- Dividend Yield
- 0.58%
Xenon Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $3.48B
- P/E
- unprofitable
Acadia Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $3.48B
- P/E
- 9.1
Liquidia Corporation
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $3.48B
- P/E
- 28.0
Parabilis Medicines, Inc.
Healthcare / Biotechnology
- Market Cap
- $3.44B
- P/E
- unprofitable
IDEAYA Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $3.42B
- P/E
- unprofitable
Showing 151–200 of 1,092 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.